|
시장보고서
상품코드
2008903
코골이 방지 치료 시장 보고서 : 디바이스 유형별, 판매 채널, 지역별(2026-2034년)Anti-Snoring Treatment Market Report by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure Devices, and Others), Distribution Channel, and Region 2026-2034 |
||||||
세계의 코골이 방지 치료 시장 규모는 2025년에 19억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 36억 달러에 달하며, 2026-2034년에 CAGR 7.24%로 성장할 것으로 예측하고 있습니다.
코골이는 목의 연조직의 진동으로 인해 코와 입에서 나는 시끄러운 호흡 소리를 말합니다. 의학적인 치료법으로는 수술이나 지속적 양압호흡요법(CPAP)이 사용됩니다. CPAP는 코와 입에 마스크를 착용하고 기계로 연결하여 비강에 일정한 공기 흐름을 주입하는 방식입니다. 또한 체중 관리, 코막힘 해소, 수면시 체위 변경, 알코올 및 진정 작용이 있는 약물 섭취를 피하는 등의 생활습관 개선으로도 개선이 가능합니다.
코골이 치료 시장 동향:
코골이 치료를 돕는 기기의 기술 발전은 시장에 긍정적인 영향을 미치는 주요 요인 중 하나입니다. 또한 장기간 코를 골면 피로, 심장마비, 고혈압, 뇌졸중, 제2형 당뇨병, 혈중 산소 농도 저하 등의 위험이 높아집니다. 이 외에도 크고 잦은 코골이는 수면무호흡증 증후군의 징후 중 하나입니다. 수면무호흡증후군은 수면 중 얕은 호흡과 호흡 정지가 특징인 만성질환입니다. 이 질환은 녹내장, 암, 인지 기능 장애 및 행동 장애를 유발할 수 있습니다. 또한 수면무호흡증 환자는 운전 적성에 영향을 미칠 수 있으므로 자동차 사고의 위험이 높아질 수 있습니다. 그 결과, 코골이 치료를 위해 코골이 방지 앱, 행동 치료, 치과용 장치, 혀 고정 장치(TSD), 하악 전돌 장치(MAD)(하악 전돌 장치(JAD)라고도 함)의 사용이 증가하고 있으며, 이는 시장 성장을 촉진하고 있습니다. 또한 좌식 생활, 건강에 해로운 식습관, 담배와 알코올 섭취 증가, 일반인의 수면장애 유병률 증가 등의 요인으로 인해 시장 전망이 밝을 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 코골이 방지 치료 시장
제6장 시장 내역 : 디바이스 유형별
제7장 시장 내역 : 유통 채널별
제8장 시장 내역 : 지역별
제9장 SWOT 분석
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
제12장 가격 분석
제13장 경쟁 구도
KSA 26.04.30The global anti-snoring treatment market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.24% during 2026-2034.
Snoring refers to a noisy breathing sound coming through the nose or mouth of an individual, which is caused by the vibration of the soft tissues of the throat. It is medically treated using surgery or continuous positive airway pressure (CPAP), wherein a mask is worn over the nose or mouth and attached to a machine for delivering a constant flow of air into the nostrils. It can also be cured via lifestyle changes, such as maintaining body weight, relieving the nasal obstruction, changing sleep positions, and avoiding alcohol and sedating medications.
ANTI-SNORING TREATMENT MARKET TRENDS:
Rising technological advancements in devices that support anti-snoring treatment represent one of the key factors positively influencing the market. Moreover, long-term snoring increases the risk of developing fatigue, heart attacks, hypertension, stroke, type 2 diabetes, and decreased blood oxygen levels. Besides this, loud and frequent snoring is one of the signs of sleep apnea, which is a chronic condition characterized by shallow breaths or pauses in breathing during sleep. This condition can lead to glaucoma, cancer, and cognitive and behavioral disorders. In addition, people with sleep apnea have an increased threat of motor vehicle accidents as it can affect driving fitness. Consequently, there is a rise in the usage of anti-snoring apps, behavioral therapies, dental devices, tongue stabilizing devices (TSD), and mandibular advancing devices (MAD), also known as jaw advancing devices (JAD), to treat snoring, which is fueling the market growth. Furthermore, factors like sedentary lifestyles, unhealthy dietary habits, increasing tobacco and alcohol consumption, and the rising prevalence of sleep disorders among the masses are projected to create a positive outlook for the market.
KEY MARKET SEGMENTATION:
Breakup by Device Type:
- Mandibular Advancement Devices (MAD)
- Tongue Stabilizing Devices (TSD)
- Continuous Positive Airway Pressure (CPAP) Devices
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, The Pure Sleep Company and Tomed GmbH.
KEY QUESTIONS ANSWERED IN THIS REPORT
1. How big is the global anti-snoring treatment market?
2. What is the expected growth rate of the global anti-snoring treatment market during 2026-2034?
3. What are the key factors driving the global anti-snoring treatment market?
4. What has been the impact of COVID-19 on the global anti-snoring treatment market?
5. What is the breakup of the global anti-snoring treatment market based on the device type?
6. What is the breakup of the global anti-snoring treatment market based on the distribution channel?
7. What are the key regions in the global anti-snoring treatment market?
8. Who are the key players/companies in the global anti-snoring treatment market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anti-Snoring Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Device Type
- 6.1 Mandibular Advancement Devices (MAD)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Tongue Stabilizing Devices (TSD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Continuous Positive Airway Pressure (CPAP) Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Distribution Channel
- 7.1 Hospital Pharmacies
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Retail Pharmacies
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Online
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Airway Management Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.2 Apnea Sciences Corporation
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Fisher & Paykel Healthcare Corporation Limited
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.4 Koninklijke Philips N.V.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 MEDiTAS Ltd.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 Medtronic plc
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Mitsui Chemicals Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 ResMed Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Rotech Healthcare Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.10 SomnoMed
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.11 The Pure Sleep Company
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.12 Tomed GmbH
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.1 Airway Management Inc.
